Andrzej Kalinski
Rock Hill, SCNPI 1639179203
Payments from drug & device makers
$1,531,782in general payments, 2019–2025
Across 834 payments — averaging $1836.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$857K
- CSL Plasma Inc.$675K
What the payments were for
- Consulting fees$1,531,782100%
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 480 | $857,079 |
| CSL Plasma Inc. | 354 | $674,703 |
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 16 | $4,182 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.